What's New on the FDA Drugs Site
April 29, 2016
- FDA approves first generic Crestor
- FDA Drug Shortages
- Atropine Sulfate Injection (Updated - Currently in Shortage)
- Bleomycin Sulfate for Injection (Updated - Currently in Shortage)
- Calcium Chloride Injection, USP (Updated - Currently in Shortage)
- Calcium Gluconate Injection (Updated - Currently in Shortage)
- Cefepime Injection (Updated - Currently in Shortage)
- Epinephrine Injection (Updated - Currently in Shortage)
- Imipenem and Cilastatin for Injection, USP (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
- Morphine Sulfate Injection, USP, CII, (Preservative-Free)(For PCA Use Only) (Updated - Currently in Shortage)
- Multi-Vitamin Infusion (Adult and Pediatric) (Updated - Currently in Shortage)
- Penicillin G Benzathine (Bicillin L-A) Injection (New - Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated - Currently in Shortage)
- Potassium Chloride Injection (Updated - Currently in Shortage)
- Sodium Bicarbonate Injection, USP (Updated - Currently in Shortage)
- Sodium Chloride 23.4% Injection (Updated - Currently in Shortage)
- Sumatriptan (Imitrex) Nasal Spray (Updated - Currently in Shortage)
- Vancomycin Hydrochloride for Injection, USP (Updated - Currently in Shortage)
- Generic Drug Review Dashboard Report (update)
- GDUFA Reauthorization Negotiation Sessions (updated)
- Public Meeting on Patient-Focused Drug Development for Huntington’s and Parkinson’s Diseases(updated)
- Voice of the Patient: A Series of Reports from FDA's Patient-Focused Drug Development Initiative(updated)
No hay comentarios:
Publicar un comentario